Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  cancer stemness kinase inhibitor BBI503
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBIHCC-103, NCI-2014-02447, NCT02279719
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: BBI503-205GYN-M, NCI-2015-01020, NCT02432690
Start Over